Stem cell treatment for ovarian cancer

Name: Mrs. Wang
Gender: Female
Country: China
Age: 53
Diagnosis: Ovarian Cancer
Treatment method: Embryonic multi-potent stem cells and embryonic hematopoietic stem cells transplantation

Background

Mrs. Wang is a 53 year old patient, who experienced an ovarian cancer surgery more than 6 years ago, at the time of her diagnosis. Her uterus, fallopian tubes, ovary and diaphragm metastases were removed in the operation. The postoperative diagnosis was grade 3 type C. She received six rounds of chemotherapy with Paclitaxel and Carboplatin. Her recovery was acceptable.

In 2005, she relapsed as the Ca125 number rose up to 250, no lesions could be found. Then, she was prescribed Chinese Medicine. However, the Cancer was not controlled. So she accepted six rounds of systemic chemotherapy again with Cranberries Liposome, Carboplatin and P53 gene medicine. The review of tumor markers returned to normal after the chemotherapy.

Radiologic review in March 2007 revealed that there were metastases in both the liver and the abdominal cavity. Radiotherapy was offered to her for several times after that. In June 2007, metastasis to brain occurred, which led to the left hemiplegia. So, she received an operation and radiotherapy more than 20 times after surgery.

In August 2007, metastasis to the liver occurred again, and she accepted systemic chemotherapy with Paclitaxel, Carboplatin, and Avastin. Her recovery postoperative was slow. She always felt weak, with dizziness, sweating and other symptoms. Her appetite and sleep quality were poor. She experienced the CIK plus DC treatment for twice in March and April 2008, and the symptoms were relieved to some extent after the treatment. In November 2008, metastasis to the liver occurred, so she underwent an operation again. In December 2008, she adopted Oxygen plus Target Therapy.

Medical condition pre-stem cell treatment

Before Stem Cell Treatment, her mental spirit was ok, but she felt somewhat weak. Her appetite and sleeping quality were poor, while both the bowel and bladder function were normal. No abnormal imaging was found in radiologic examination. However, she received mild hematopoietic suppression and the number of her red blood cells, white blood cells and platelets were lower than normal, possibly from the frequent chemotherapy and radiotherapy.

Treatment

Embryonic multi-potent stem cells and embryonic hematopoietic stem cells transplantation

Medical condition post-stem cell treatment

On March 31st 2009, she accepted her first embryonic tissue stem cell transplantation (embryonic multi-potent stem cells and embryonic hematopoietic stem cells transplantation). The next day she felt that she could see more clearly than before, and had the symptoms of accelerated metabolism, for example sweating. A week later, she could eat more food and her sleeping quality was obviously improved. Two weeks later, the blood routine review showed that the white blood cells, red blood cells, hemoglobin and platelets had gradually reversed. So she received the embryonic tissue stem cell transplantation for the second time on May 1st 2009. Then, she underwent twice embryo stem cell transplantation on May 26th and June 15th 2009. There was no adverse effect after the transplantation.

Now she is conscious, and feels excellent. Her appetite and sleeping quality are normal. Her bowel and bladder functions are normal. Vital signs are stable and the functions of heart and lung are normal. She has energy, feels powerful, and her vision has returned normal.